EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment

Stavros P Papadakos iD, Nikolaos Dedes, Nikolina Gkolemi, Nikolaos Machairas iD, Stamatios Theocharis

International Journal of Molecular Sciences · 03.02.2023 · 24 (3) · 3015

DOI: 10.3390/ijms24033015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2023. Verfasst von Stavros P Papadakos und 4 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Ephrins, Adenocarcinoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a major concern for health care systems worldwide, since its mortality remains unaltered despite the surge in cutting-edge science. The EPH/ephrin signaling system was first investigated in the 1980s. EPH/ephrins have been shown to exert bidirectional signaling and cell-to-cell communication, influencing cellular morphology, adhesion, migration and invasion. Recent studies have highlighted the critical role of the EPH/ephrin system in various physiologic processes, including cellular proliferation, survival, synaptic plasticity and angiogenesis. Thus, it has become evident that the EPH/ephrin signaling system may have compelling effects on cell homeostasis that contribute to carcinogenesis. In particular, the EPH/ephrins have an impact on pancreatic morphogenesis and development, whereas several EPHs and ephrins are altered in PDAC. Several clinical and preclinical studies have attempted to elucidate the effects of the EPH/ephrin pathway, with multilayered effects on PDAC development. These studies have highlighted its highly promising role in the diagnosis, prognosis and therapeutic management of PDAC. The aim of this review is to explore the obscure aspects of the EPH/ephrin system concerning the development, physiology and homeostasis of the pancreas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EphrinsAdenocarcinomaHumansReceptors, Eph FamilySignal TransductionPancreas

Stichwörter der Autor:innen

EPH/eprinPDACimmunotherapypancreatic cancersignaling pathway

Substanzen

EphrinsReceptors, Eph Family

Autor:innen und Institutionen

  • First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Second Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, 11527 Athens, Greece.

ORCID-Profile: Stavros P Papadakos, Nikolaos Machairas

Zitieren

APA

Papadakos, S. P., Dedes, N., Gkolemi, N., Machairas, N., & Theocharis, S. (2023). The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences, 24(3), 3015. https://doi.org/10.3390/ijms24033015

Vancouver

Papadakos SP, Dedes N, Gkolemi N, Machairas N, Theocharis S. The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. International Journal of Molecular Sciences. 2023;24(3):3015. doi:10.3390/ijms24033015

BibTeX
@article{Papadakos2023,
  author = {Papadakos, Stavros P and Dedes, Nikolaos and Gkolemi, Nikolina and Machairas, Nikolaos and Theocharis, Stamatios},
  title = {The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {3015},
  doi = {10.3390/ijms24033015}
}
Kostenlos starten →